Andrea Fidanzio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea Fidanzio has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Angelo Piermattei
Università Cattolica del Sacro Cuore
49 shared publications - Luigi Azario
Università Cattolica del Sacro Cuore
45 shared publications Savino Cilla
Istituto Nazionale di Fisica Nucleare (INFN)
16 shared publications- Alessio Giuseppe Morganti
Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40126 Bologna, Italy
12 shared publications Francesca Greco
Università Cattolica del Sacro Cuore
12 shared publications- Gabriella Macchia
Radiation Oncology Unit, Gemelli Molise Hospital, Università Cattolica del Sacro Cuore, 86100 Campobasso, Italy
12 shared publications
Latest Publications
- 1 February 2016
- Published by Elsevier in Physica Medica
- Vol. 32, 14
EPID-based in-vivo dosimetry for VMAT treatment dose verification: Initial clinical experience
- 1 February 2016
- Published by Elsevier in Physica Medica
- Vol. 32, 14
EPID-based in-vivo dosimetry for VMAT treatment dose verification: Initial clinical experience
- Open Access
- 1 April 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 115, S852
EP-1559: Initial clinical experience with EPID-based in-vivo dosimetry for VMAT treatment verification
- 1 April 2015
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 115, S852
Open AccessEP-1559: Initial clinical experience with EPID-based in-vivo dosimetry for VMAT treatment verification
- 31 March 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (8) , N141-N150
Routine EPIDin-vivodosimetry in a reference point for conformal radiotherapy treatments
In-vivo dosimetry (IVD) in external beam radiotherapy is used to detect major clinically relevant differences between planned and delivered dose. Moreover, a detailed analysis of its results, when routinely reported and discussed by the radiotherapy staff, can limit the likelihood of error transmission to many treatments. A first experience of routine EPID-based IVD in a reference point has been performed in our department for 3D-CRT treatments over a three-year period. More than 14 000 images were acquired and 1287 treatment plans were verified. The IVD checks were obtained three times in the first week and then weekly. Tolerance levels of ±5% for pelvic–abdomen, head–neck and breast irradiations and ±6% for lung treatments were adopted for the in-vivo measured dose per fraction. A statistical analysis of the IVD results was performed grouping the data by: anatomical regions, treatment units, open and wedged fields and gantry angles. About 10% of the checked doses per fraction showed dosimetric discrepancies out of the tolerance levels. The causes of the discrepancies were 70% delivery or planning errors, 20% morphological changes and 10% procedural limitations. 41 cases (3.2%) have required special investigations because their in-vivo doses per fraction, averaged over the first three sessions, were out of the tolerance levels and in 19 cases (1.5%) the deviations gave rise to an intervention. Statistically significant differences of average variations between planned and delivered doses were observed for: (i) 30° wedged 10 MV fields with respect to those of other wedged or open 10 MV fields delivered by two linacs, due to the incorrect TPS implementation of that wedge transmission factor; (ii) anterior–posterior and posterior–anterior beams with respect to the other gantry orientations for one linac, due to the beam attenuation introduced by the treatment couch; (iii) lateral fields with respect to medial fields of breast irradiations for all linacs, due to small systematic set-up variations. The analysis of our data shows a substantial homogeneity of the IVD results for all the considered body regions and treatment units. However, the observed discrepancies have supplied indications for taking further steps in the optimization process and in some cases to adopt an adaptive approach.
- 31 March 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (8) , N141-N150
Routine EPIDin-vivodosimetry in a reference point for conformal radiotherapy treatments
In-vivo dosimetry (IVD) in external beam radiotherapy is used to detect major clinically relevant differences between planned and delivered dose. Moreover, a detailed analysis of its results, when routinely reported and discussed by the radiotherapy staff, can limit the likelihood of error transmission to many treatments. A first experience of routine EPID-based IVD in a reference point has been performed in our department for 3D-CRT treatments over a three-year period. More than 14 000 images were acquired and 1287 treatment plans were verified. The IVD checks were obtained three times in the first week and then weekly. Tolerance levels of ±5% for pelvic–abdomen, head–neck and breast irradiations and ±6% for lung treatments were adopted for the in-vivo measured dose per fraction. A statistical analysis of the IVD results was performed grouping the data by: anatomical regions, treatment units, open and wedged fields and gantry angles. About 10% of the checked doses per fraction showed dosimetric discrepancies out of the tolerance levels. The causes of the discrepancies were 70% delivery or planning errors, 20% morphological changes and 10% procedural limitations. 41 cases (3.2%) have required special investigations because their in-vivo doses per fraction, averaged over the first three sessions, were out of the tolerance levels and in 19 cases (1.5%) the deviations gave rise to an intervention. Statistically significant differences of average variations between planned and delivered doses were observed for: (i) 30° wedged 10 MV fields with respect to those of other wedged or open 10 MV fields delivered by two linacs, due to the incorrect TPS implementation of that wedge transmission factor; (ii) anterior–posterior and posterior–anterior beams with respect to the other gantry orientations for one linac, due to the beam attenuation introduced by the treatment couch; (iii) lateral fields with respect to medial fields of breast irradiations for all linacs, due to small systematic set-up variations. The analysis of our data shows a substantial homogeneity of the IVD results for all the considered body regions and treatment units. However, the observed discrepancies have supplied indications for taking further steps in the optimization process and in some cases to adopt an adaptive approach.
- 1 June 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (4) , 419-426
An in-vivo dosimetry procedure for Elekta step and shoot IMRT
- 1 June 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (4) , 419-426
An in-vivo dosimetry procedure for Elekta step and shoot IMRT
- 20 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part1) , 062103
Quasi real time in vivo dosimetry for VMAT
Purpose: Results about the feasibility of a method for quasi real timein vivo dosimetry (IVD) at the isocenter point for volumetric modulated arc therapy (VMAT) are here reported. The method is based on correlations between the EPID signal and the dose on the beam central axis. Moreover, the γ‐analysis of EPID images was adopted to verify off‐axis reproducibility of fractionated plan delivery. Methods: An algorithm to reconstructin vivo the isocenter dose, Diso, for RapidArc treatments has been developed. 20 VMAT plans, optimized with two opposite arcs, for prostate, pancreas, and head treatments have been delivered by a Varian linac both to a conic PMMA phantom with elliptical section and to patients. The ratios R between reconstructed Diso and the planned doses were determined for phantom and patient irradiations adopting an acceptance criterion of ±5%. In total, 40 phantom checks and 400 patient checks were analyzed. Moreover, 3% and 3 mm criteria were adopted for portal image γ‐analysis to assess patient irradiation reproducibility. Results: The average ratio R, between reconstructed and planned doses for the PMMA phantom irradiations was equal to 1.007 ± 0.024. When the IVD method was applied to the 20 patients, the average R ratio was equal to 1.003 ± 0.017 and 96% of the tests were within the acceptance criteria. The portal image γ‐analysis supplied 88% of the tests within the pass rates γmean ≤ 0.4 and Pγ ≥ 98%. All the warnings were understood comparing the CT and the cone beam CT images and in one case a patient's setup error was detected and corrected for the successive fractions. Conclusions: This preliminary experience suggests that the method is able to detect dosimetric errors in quasi real time at the end of the therapy session. The authors intend to extend this procedure to other pathologies with the integration of in‐room imaging verification by cone beam CT.
- 20 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part1) , 062103
Quasi real time in vivo dosimetry for VMAT
Purpose: Results about the feasibility of a method for quasi real timein vivo dosimetry (IVD) at the isocenter point for volumetric modulated arc therapy (VMAT) are here reported. The method is based on correlations between the EPID signal and the dose on the beam central axis. Moreover, the γ‐analysis of EPID images was adopted to verify off‐axis reproducibility of fractionated plan delivery. Methods: An algorithm to reconstructin vivo the isocenter dose, Diso, for RapidArc treatments has been developed. 20 VMAT plans, optimized with two opposite arcs, for prostate, pancreas, and head treatments have been delivered by a Varian linac both to a conic PMMA phantom with elliptical section and to patients. The ratios R between reconstructed Diso and the planned doses were determined for phantom and patient irradiations adopting an acceptance criterion of ±5%. In total, 40 phantom checks and 400 patient checks were analyzed. Moreover, 3% and 3 mm criteria were adopted for portal image γ‐analysis to assess patient irradiation reproducibility. Results: The average ratio R, between reconstructed and planned doses for the PMMA phantom irradiations was equal to 1.007 ± 0.024. When the IVD method was applied to the 20 patients, the average R ratio was equal to 1.003 ± 0.017 and 96% of the tests were within the acceptance criteria. The portal image γ‐analysis supplied 88% of the tests within the pass rates γmean ≤ 0.4 and Pγ ≥ 98%. All the warnings were understood comparing the CT and the cone beam CT images and in one case a patient's setup error was detected and corrected for the successive fractions. Conclusions: This preliminary experience suggests that the method is able to detect dosimetric errors in quasi real time at the end of the therapy session. The authors intend to extend this procedure to other pathologies with the integration of in‐room imaging verification by cone beam CT.
- Open Access
- 9 July 2013
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 51 (10) , 1137-1145
aSi-EPID transit signal calibration for dynamic beams: a needful step for the IMRT in vivo dosimetry
This work reports a method based on correlation functions to convert EPID transit signals into in vivo dose values at the isocenter point, D iso, of dynamic IMRT beams supplied by Varian linac. Dose reconstruction for intensity-modulated beams required significant corrections of EPID response, due to the X-ray component transmitted through multileaf collimator. The algorithm was formulated using a set of simulated IMRT beams. The beams were parameterized by means of a fluence inhomogeneity index, FI, introduced to describe the degree of beam modulation with respect to open beams. This way, all dosimetric parameters involved in D iso reconstruction algorithm, such as the correlation functions, the correction factor for EPID to phantom distance and the modulated tissue maximum ratios, were determined as a function of the FI index. Clinical IMRT beams were used to irradiate a homogeneous phantom, and for each beam, the agreement between the reconstructed dose, D iso, and the dose computed by TPS, D iso,TPS, was well within 5 %. Moreover, the average ratios, R, between the D iso, and D iso,TPS, resulted equal to 1.002 ± 0.030. Thirty-five IMRT fields of 5 different patients undergoing radiotherapy for head–neck tumors were tested and the results were displayed on a computer screen after 2 min from the end of the treatment. However, 350 in vivo tests supplied an average ratio R equal to 1.004 ± 0.040. The in vivo dosimetry procedure here presented is among the objectives of a National Project financially supported by the Istituto Nazionale di Fisica Nucleare for the development of in vivo dosimetry procedures (Piermattei et al. in Nucl Instrum Methods Phys Res B 274:42–50, 2012) connected to the Record–Verify system of the radiotherapy center.
- 9 July 2013
- Published by Springer Nature in Medical & Biological Engineering & Computing
- Vol. 51 (10) , 1137-1145
Open AccessaSi-EPID transit signal calibration for dynamic beams: a needful step for the IMRT in vivo dosimetry
This work reports a method based on correlation functions to convert EPID transit signals into in vivo dose values at the isocenter point, D iso, of dynamic IMRT beams supplied by Varian linac. Dose reconstruction for intensity-modulated beams required significant corrections of EPID response, due to the X-ray component transmitted through multileaf collimator. The algorithm was formulated using a set of simulated IMRT beams. The beams were parameterized by means of a fluence inhomogeneity index, FI, introduced to describe the degree of beam modulation with respect to open beams. This way, all dosimetric parameters involved in D iso reconstruction algorithm, such as the correlation functions, the correction factor for EPID to phantom distance and the modulated tissue maximum ratios, were determined as a function of the FI index. Clinical IMRT beams were used to irradiate a homogeneous phantom, and for each beam, the agreement between the reconstructed dose, D iso, and the dose computed by TPS, D iso,TPS, was well within 5 %. Moreover, the average ratios, R, between the D iso, and D iso,TPS, resulted equal to 1.002 ± 0.030. Thirty-five IMRT fields of 5 different patients undergoing radiotherapy for head–neck tumors were tested and the results were displayed on a computer screen after 2 min from the end of the treatment. However, 350 in vivo tests supplied an average ratio R equal to 1.004 ± 0.040. The in vivo dosimetry procedure here presented is among the objectives of a National Project financially supported by the Istituto Nazionale di Fisica Nucleare for the development of in vivo dosimetry procedures (Piermattei et al. in Nucl Instrum Methods Phys Res B 274:42–50, 2012) connected to the Record–Verify system of the radiotherapy center.
- 1 January 2013
- Published by Springer Nature
- p. 1233-1236
A Generalized in-vivo Dosimetry Procedure for Conformal Radiotherapy by Means of EPIDs: First Results of a National Italian Project
- 1 January 2013
- Published by Springer Nature
- p. 1233-1236
A Generalized in-vivo Dosimetry Procedure for Conformal Radiotherapy by Means of EPIDs: First Results of a National Italian Project
- Open Access
- 1 September 2011
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 12 (4) , 124-138
Real-time dose reconstruction for wedged photon beams: a generalized procedure
A practical and accurate generalized procedure to reconstruct the isocenter dose Diso for 3D conformal radiotherapy (3DCRT) has been developed for X‐ray open beams supplied by linacs of different manufacturers and equipped with aSi electronic portal imaging devices (aSi EPIDs). This paper reports an extension of the method, to be applied at the wedged X‐ray beams characterized by the wedge attenuation factor WAF.
- 1 September 2011
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 12 (4) , 124-138
Open AccessReal-time dose reconstruction for wedged photon beams: a generalized procedure
A practical and accurate generalized procedure to reconstruct the isocenter dose Diso for 3D conformal radiotherapy (3DCRT) has been developed for X‐ray open beams supplied by linacs of different manufacturers and equipped with aSi electronic portal imaging devices (aSi EPIDs). This paper reports an extension of the method, to be applied at the wedged X‐ray beams characterized by the wedge attenuation factor WAF.